Red List:Official warnings and scam reports, with sourcesCheck a link
Check a link
Enforcement actionResolvedCaution

HempmeCBD

Agreed to an FTC consent order over allegedly unsupported claims that CBD treats cancer symptoms and AIDS

This entry is about the United States — not the country you picked in the header.

According to Federal Trade Commission, Dec 17, 2020 · Read the source · +1 more

Where
United States
First reported
Last checked

Resolved or closed

The source lists this matter as resolved or closed. The entry stays public so the record remains available.

Summary

HempmeCBD, which the FTC identified as also operating as EasyButter, LLC, was one of six CBD sellers in the agency's December 2020 Operation CBDeceit sweep. The FTC said the company had sold CBD products online since January 2018, including CBD-infused shea butter, gummies, lozenges, honey sticks, vape pens and oils. It alleged that the marketing claimed the products could treat or cure serious problems such as cancer-related symptoms, substance abuse and AIDS, and falsely claimed that studies supported CBD use for autism. Under an administrative consent order finalized on March 5, 2021, the respondents must not make disease claims without human clinical testing, must support other health claims with scientific evidence, had to pay the FTC $36,254 and had to notify consumers of the order. The FTC lists the case as closed.

What the source found

  • The FTC alleged claims that the products treat or cure cancer-related symptoms, substance abuse and AIDS.
  • The FTC also alleged false claims that studies support CBD for autism.
  • The consent order requires human clinical testing for disease claims and scientific evidence for other health claims.
  • The respondents were required to pay $36,254 to the FTC and notify consumers.

Products named

  • CBD topicals (shea butter)
  • CBD gummies and lozenges
  • CBD vape pens
  • CBD oils

Timeline

  1. FTC announces administrative complaint and proposed consent order

  2. FTC approves final decision and order; case closed

Sources

  1. Regulator
  2. Regulator

    Federal Trade Commission · Mar 5, 2021

    HempmeCBD, In the Matter of

Wording on this page follows the sources. Found an error? See the corrections process in our editorial policy.

Status notes

Settled through an administrative consent order in 2021; the FTC lists the case as closed. The order's restrictions on health claims remain in force. Current trading status of the business was not verified.

Comments

No comments yet.

Comments are read by a moderator before they’re published.

The full Red List
Enforcement actionOfficial action

Herbal Pathways, LLC d/b/a HiBrid

HiBrid

Massachusetts regulator order over sales of products with out-of-date test results in Pittsfield

United States · Sep 18, 2026
Enforcement actionOfficial action

Empire 1 Convenience CORP

Empire 1 Convenience CORP

NYC Sheriff summons for a cannabis violation by a place of business

United States · Sep 18, 2026
Enforcement actionOfficial action

Purple Sky 1 CORP

Purple Sky 1 CORP

NYC Sheriff summons for a cannabis violation by a place of business

United States · Sep 17, 2026
Report a seller

Tell us what happened

Every report is read by a person. You don’t need to prove anything, and we never publish your name.

What happens next
  • A moderator reads your report and checks the link against the Red List and our seller records.
  • We look for an authoritative source — a regulator, court, police or consumer-protection finding.
  • When a source confirms it, your report is linked to a Red List entry. Your name and contact details stay private.
Report a seller

Self-check · 2 minutes · private

Is cannabis becoming a problem for you?

Eight questions from CUDIT-R, a screening test used by clinicians. Your answers never leave this page.